Seronics Co., Ltd

As of March 31, 2026, Seronics Co., Ltd carries a market capitalization of 187.47B, placing it among publicly traded companies globally. Its enterprise value stands at 256.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Seronics Co., Ltd has 12.42M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 1.16, and the price-to-book ratio stands at 2.05.

As of March 31, 2026, Seronics Co., Ltd trades at an EV/EBITDA multiple of 313.22 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.61 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 256.19B versus a market cap of 187.47B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Seronics Co., Ltd maintains a current ratio of 0.70, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 98.61, indicating elevated leverage, while an interest coverage ratio of 0.18 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Seronics Co., Ltd posted a negative return on equity (ROE) of -17.55, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -7.53, reflecting losses generated across the asset base. The company generates approximately 263.89M in revenue per employee across its workforce of 604.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 9.09 indicates how many times Seronics Co., Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Seronics Co., Ltd recorded an income tax benefit of -3.70B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -21.22B and -17.19B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Seronics Co., Ltd's stock has declined approximately 38.30% over the past 52 weeks. The 50-day moving average sits at 11,607.20, while the 200-day moving average is 13,409.75.

Over the twelve months ended March 31, 2026, Seronics Co., Ltd generated 159.39B in revenue and converted that into -17.19B in net income, yielding earnings per share of -1,429.65. EBITDA reached 817.94M, while operating income came in at -3.08B.

As of March 31, 2026, Seronics Co., Ltd holds 33.01B in cash and equivalents against 95.96B in total debt, resulting in a net debt position of 60.11B. Total book value stands at 91.54B, with working capital of -33.58B providing operational flexibility.

Seronics Co., Ltd produced 2.41B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -2.52B in capital expenditures, free cash flow totaled -109.64M - equivalent to -8.94 per share.

Over the twelve months ended March 31, 2026, Seronics Co., Ltd posted a gross margin of 7.48, reflecting its pricing power and cost economics. The operating margin of -1.93 and net profit margin of -10.78 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Seronics Co., Ltd paid dividends of -NaN per share. The dividend payout ratio of -NaN indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -0.06: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.69, meaning Seronics Co., Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of March 31, 2026, Seronics Co., Ltd has an Altman Z-Score of 1.80, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.